The efficacy of medroxyprogesterone acetate (MPA) in women with endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization

The paper reports on the efficacy of medroxyprogesterone acetate (MPA) in women with endometriosis who were undergoing controlled ovarian hyperstimulation for in vitro fertilization. The study design and methods are described at a high level, with treatment using MPA in the context of fertility-cycle hormonal protocols. The paper’s primary result is presented as an assessment of MPA’s efficacy during this IVF-related setting, though the text provided does not include specific outcome metrics or detailed limitations. This paper is centrally about endometriosis — it evaluates MPA efficacy for women with endometriosis undergoing controlled ovarian hyperstimulation for IVF.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works